Synthesis and Biological Evaluation of Marine-Inspired Benzothiazole Derivatives as Retinoid X Receptor-α Antagonists with Anti-Cancer Activities
Marine Drugs · 2025
DOI: 10.3390/md23090368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Yingting Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, China. Hauptthemen laut MEDLINE: Benzothiazoles, Antineoplastic Agents, Retinoid X Receptor alpha. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Retinoid X receptor α (RXRα) plays a vital role in multiple biological and pathological processes and represents a promising therapeutic target for anti-tumor drug design. Inspired by the marine-derived RXRα antagonist meroterpenthiazole A, 21 undescribed benzothiazole derivatives were designed and synthesized. The inhibitory effects of 21 derivatives on RXRα transactivation and their anti-tumor activities against MDA-MB-231 cells were evaluated. Compounds 4a–4h, 6a–6b, 7c–7f, and 7h–7i inhibited 9-cis-retinoic acid-induced RXRα transactivation, while compounds 3b, 4f–4h, 7a, 7c, 7f, and 7h–7i exhibited inhibitory effects on the proliferation of MDA-MB-231 cells. Meanwhile, the structure–activity relationships governing both the RXRα antagonist effects and the anti-proliferative activities against MDA-MB-231 cells were discussed. Compound 7i exhibited the most potent inhibitory effects on the proliferation of MDA-MB-231 cells with an IC50 value of 16.5 μM. Further mechanism studies revealed that compound 7i induced G2/M phase arrest in MDA-MB-231 cells, accompanied by dose-dependent downregulation of Cyclin B1 and CDK1 protein expression. However, these effects were abolished in RXRα-knockout MDA-MB-231 cells, indicating that the anti-proliferative and cell cycle arrest activities of 7i were RXRα-dependent. Cellular Thermal Shift Assay (CETSA) and molecular docking studies further confirmed that 7i directly bound to RXRα, thereby mediating its anti-cancer efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, China.
ORCID-Profile: Junjie Chen, Haifeng Chen
Förderung
- the National Key Research and Development Program of China
- National Key Research and Development Program of China
Zitieren
APA
Lin, Y., Peng, M., Yang, R., Wang, G., Chen, J., Ding, R., Sun, C., Tian, W., & Chen, H. (2025). Synthesis and Biological Evaluation of Marine-Inspired Benzothiazole Derivatives as Retinoid X Receptor-α Antagonists with Anti-Cancer Activities. Marine Drugs. https://doi.org/10.3390/md23090368
Vancouver
Lin Y, Peng M, Yang R, Wang G, Chen J, Ding R, et al. Synthesis and Biological Evaluation of Marine-Inspired Benzothiazole Derivatives as Retinoid X Receptor-α Antagonists with Anti-Cancer Activities. Marine Drugs. 2025. doi:10.3390/md23090368
BibTeX
@article{Lin2025,
author = {Lin, Yingting and Peng, Ming and Yang, Renjing and Wang, Guanghui and Chen, Junjie and Ding, Rong and Sun, Cuiling and Tian, Wenjing and Chen, Haifeng},
title = {Synthesis and Biological Evaluation of Marine-Inspired Benzothiazole Derivatives as Retinoid X Receptor-α Antagonists with Anti-Cancer Activities},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090368}
}
EUVIMED